Corcept Therapeutics Faces Class Action Over FDA Data Misrepresentation Corcept Therapeutics is embroiled in a class action lawsuit for allegedly misleading investors regarding FDA concerns over their drug candidate.

Corcept Therapeutics Faces Class Action Over FDA Data Misrepresentation #United_States #Class_Action #San_Francisco #Corcept_Therapeutics #FDA_concerns

Pomerantz Law Firm Investigates Securities Fraud Claims Against Disc Medicine, Inc. Pomerantz Law Firm is probing potential securities fraud involving Disc Medicine, Inc. after the company’s stock fell due to FDA concerns. Investors are encouraged to contact the firm for more info.

Pomerantz Law Firm Investigates Securities Fraud Claims Against Disc Medicine, Inc. #USA #New_York #Pomerantz_Law #FDA_concerns #Disc_Medicine

Investigation Launched by Pomerantz Law Firm for UroGen Pharma Investors' Claims Pomerantz Law Firm is conducting an investigation into potential securities fraud involving UroGen Pharma Ltd., after FDA concerns about its bladder cancer drug led to a significant drop in stock price.

Investigation Launched by Pomerantz Law Firm for UroGen Pharma Investors' Claims #United_States #New_York #Class_Action #UroGen_Pharma #FDA_concerns